Abbott To Acquire Cephea Valve Technologies, Inc.

Author's Avatar
Jan 16, 2019
Article's Main Image

Acquisition to further bolster Abbott's leading position in therapies for mitral valve disease, the most common type of heart valve ailment

PR Newswire